Anti-inflammatory effect and antihepatoma mechanism of carrimycin

doi:10.3748/wjg.v29.i14.2134

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3576)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series, Tables (1-2) series.

Item

Count

PDF

148

WORD

HTML

1909

Figures (1-10)

433

Tables (1-2)

323

Sum=2845

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

163

Download

568

Sum=731

Apr 14, 2023 (publication date) through Dec 30, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Apr 14, 2023; 29(14): 2134-2152
Published online Apr 14, 2023. doi: 10.3748/wjg.v29.i14.2134

Full Size Figure Download Figure

Figure 9 Target-pathway network of carrimycin. The nodes include 60 related targets displayed as yellow rectangles and 20 signaling pathways indicated in red type V. The main targets acting on the pathway include MAPK1, MAP2K1, and EGFR, etc.

Citation: Li XY, Luo YT, Wang YH, Yang ZX, Shang YZ, Guan QX. Anti-inflammatory effect and antihepatoma mechanism of carrimycin. World J Gastroenterol 2023; 29(14): 2134-2152
URL: https://www.wjgnet.com/1007-9327/full/v29/i14/2134.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i14.2134